Administration Of Biologically And Clinically Relevant Doses Of The Farnesyl Transferase Inhibitor R115777 And Gemcitabine Are Feasible Without Pharmacokinetic (Pk) Interactions: A Phase I And Pk Study.
CLINICAL CANCER RESEARCH（2000）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要